Komal Narula, MD
Obstetrics & Gynecology · Columbus, OHNPI 1184724890
Payments from drug & device makers
Across 204 payments — averaging $17.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Astellas Pharma US Inc$345
- Mayne Pharma Commercial LLC$293
- Aspira Women's Health Inc$264
- Agile Therapeutics, Inc.$159
- Hologic Sales And Service, LLC$148
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,597100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 66 | $1,015 |
| Astellas Pharma US Inc | 12 | $345 |
| Mayne Pharma Commercial LLC | 21 | $293 |
| Aspira Women's Health Inc | 8 | $264 |
| Agile Therapeutics, Inc. | 9 | $159 |
| Hologic Sales And Service, LLC | 5 | $148 |
| Exeltis, USA Inc. | 9 | $132 |
| Sumitomo Pharma America, Inc. | 7 | $130 |
| Daiichi Sankyo Inc. | 7 | $120 |
| Evofem Biosciences, Inc. | 7 | $104 |
| Pacira Pharmaceuticals Incorporated | 4 | $104 |
| Myovant Sciences Inc. | 4 | $91 |
| Therapeuticsmd, Inc. | 6 | $82 |
| Organon | 7 | $69 |
| Mylan Pharmaceuticals Inc. | 3 | $62 |
| Biogen | 3 | $56 |
| Shield Therapeutics Inc | 3 | $51 |
| Bayer | 3 | $50 |
| Coopersurgical, Inc. | 2 | $44 |
| Amgen | 2 | $38 |
| Pfizer | 2 | $35 |
| Minerva Surgical, Inc | 2 | $32 |
| Novo Nordisk | 1 | $23 |
| Gynesonics, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Merck | 1 | $17 |
| Novum Pharma, LLC | 1 | $16 |
| Coloplast | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Lupin Inc. | 1 | $12 |
| Avion Pharmaceuticals | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$125
How this compares
$3,609 in reported general payments places this provider in the 85th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Columbus
- Harold GreenColumbus$2.3M
- Michelle IsleyColumbus$252K
- Katherine RivlinColumbus$217K
- Milroy SamuelColumbus$208K
- Uma AnanthColumbus$120K
- Erin OlahColumbus$97K
- David PortmanColumbus$94K
- Anita SomaniColumbus$93K
- Mervyn SamuelColumbus$92K
- Jacqueline RohlColumbus$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.